The coronavirus crisis in South Africa is far from over despite falling case numbers in recent weeks. The virus has claimed more than of 50,000 lives, and many health experts predict a devastating third wave. Complicating matters is a new coronavirus mutation known as n501, which threatens to upend South Africa’s vaccination plans.
Unprecedented scientific collaboration has expedited the development of the new vaccine candidates, but patents protecting the bottom lines of the pharmaceutical companies have hampered efforts to manufacture vaccines at scale. Meanwhile, the United States and Western Europe have hoarded limited supplies through bilateral negotiations with Big Pharma. Developing nations in the Global South have been left behind.
The post The Global South Faces A ‘Vaccine Apartheid’ appeared first on PopularResistance.Org.
This post was originally published on PopularResistance.Org.
